RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Bradenton, FL · Kissimmee, FL · Largo, FL · +57 more sites
Ulcerative Colitis clinical trials in Orlando, FL
17 recruiting ulcerative colitis studies with a site in Orlando, FL.
RecruitingPhase 4NCT06581328
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Sponsor: Takeda
Brooksville, FL · Clearwater, FL · Hialeah, FL · +98 more sites
RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Hialeah, FL · Jacksonville, FL · Kissimmee, FL · +37 more sites
RecruitingPhase 2NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Sponsor: Eli Lilly and Company
Daytona Beach, FL · Kissimmee, FL · Lakewood Rch, FL · +49 more sites
RecruitingPhase 3NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Sponsor: Eli Lilly and Company
Miami, FL · Orlando, FL · +34 more sites
RecruitingPhase 2NCT07296315
Confirmatory Clinical Study in Active Ulcerative Colitis
Sponsor: MRM Health NV
Miami, FL · Orlando, FL · Palmetto Bay, FL · +3 more sites
RecruitingPhase 2NCT07845487
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Palisade Bio
Orlando, FL · +29 more sites
RecruitingPhase 2NCT07463183
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Sponsor: Merck Sharp & Dohme LLC
Inverness, FL · Miami, FL · Orlando, FL · +8 more sites
RecruitingPhase 2 / Phase 3NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Sponsor: Bristol-Myers Squibb
Orlando, FL · +35 more sites
RecruitingPhase 4NCT06095128
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Sponsor: Takeda
Orlando, FL · Tampa, FL · +35 more sites
RecruitingPhase 3NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Clermont, FL · Coral Springs, FL · Gainesville, FL · +115 more sites
RecruitingNot applicableNCT05230173
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Sponsor: Mayo Clinic
Jacksonville, FL · Orlando, FL · +22 more sites
RecruitingPhase not listedNCT07237516
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Sponsor: University of North Carolina, Chapel Hill
Miami, FL · Orlando, FL · +9 more sites
RecruitingPhase not listedNCT06398626
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Sponsor: Pfizer
Kissimmee, FL · Lutz, FL · Orlando, FL · +25 more sites
RecruitingPhase 2NCT05287126
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Sponsor: Pfizer
Orlando, FL · +19 more sites
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Miami, FL · +43 more sites
RecruitingNot applicableNCT05987852
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
Sponsor: Northwestern University
Miami, FL · Orlando, FL · +11 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.